1[1]Naot D,Sionov RV,Ish Shalom D. CD44:structure,function,and assiociation with the malignant process [J]. Adv Cancer Res,1997,71:241- 319.
2[2]Herrera Gayol A,Jothy S. Adhesion protein in the biology of breast cancer: contribution of CD44 [J]. Exp Mol Pathol,1999,66(2):149- 156.
3[3]Kaufmann M,Heider KH,Sinn HP,et al. CD44 variant exon epitpes in primary breast cancer and length of survival [J]. Lancet,1995,345(8950):615- 619.
4[4]Dall P,Herider KH,Sinn HP,et al. Comparison of immunohistochemistry and RT PCR for detection of CD44v expression,a new prognostic factor in human breast cancer [J]. Int J Cancer,1995,60(4):471- 477.
5[5]Rosen PP,Oberman HA. Tumors of the Mammary Gland [M]. Washington D.C: Armed Forces Institute of Pathology,1992,72- 76.
6[6]Papotti M,Eusebi V,Gugliotta P,et al. Immunohistochemical analysis of benign and malignant papillary lesions of the breast [J]. Am J Surg Pathol,1983,7(5):451- 461.
7[7]Mackay CR,Terpe HJ,Stauder R,et al. Expression and modulation of CD44 variant isoforms in humans [J]. J Cell Biol,1994,124(1- 2):71- 82.
8[8]Mastsumura Y,Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation [J]. Lancet,1992,340(8827):1053- 1058.
9[9]Bankfalvi A,Terpe HJ,Breukelmann D,et al. Gains and losses of CD44 expression during breast carcinogenesis and tumour progression [J]. Histopathology,1998,33(2):107- 116.
10[10]Friedrichs K,Franke F,Lisboa BW,et al. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer [J]. Cancer Res,1995,55(22):5424- 5433.
4Fisher B,Anderson S.Conservative surgery for management of invasive and noninvasive carcinoma of the breast NSABP trials[J]World J Surgy,1994,18(1):63.
